Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).
Maitland-van der Zee, Anke-Hilse
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS). [electronic resource] - Acta cardiologica Jun 2006 - 327-31 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0001-5385
10.2143/AC.61.3.2014836 doi
Aged
Anticholesteremic Agents--therapeutic use
Apolipoprotein E2--genetics
Apolipoprotein E3--genetics
Apolipoprotein E4--genetics
Apolipoproteins E--genetics
Cholesterol--blood
Cholesterol, HDL--blood
Cholesterol, LDL--blood
Coronary Artery Disease--blood
Genetic Carrier Screening
Genetic Predisposition to Disease--genetics
Genotype
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Male
Middle Aged
Polymorphism, Genetic--genetics
Pravastatin--therapeutic use
Regression Analysis
Statistics as Topic
Treatment Outcome
Triglycerides--blood
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS). [electronic resource] - Acta cardiologica Jun 2006 - 327-31 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0001-5385
10.2143/AC.61.3.2014836 doi
Aged
Anticholesteremic Agents--therapeutic use
Apolipoprotein E2--genetics
Apolipoprotein E3--genetics
Apolipoprotein E4--genetics
Apolipoproteins E--genetics
Cholesterol--blood
Cholesterol, HDL--blood
Cholesterol, LDL--blood
Coronary Artery Disease--blood
Genetic Carrier Screening
Genetic Predisposition to Disease--genetics
Genotype
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Male
Middle Aged
Polymorphism, Genetic--genetics
Pravastatin--therapeutic use
Regression Analysis
Statistics as Topic
Treatment Outcome
Triglycerides--blood